During this process, breast cancer cells are switched between non-CSCs and CSCs by selective splicing of CD44 into CD44v or CD44s, and cancer cells with high levels of CD44v lose CSC stemness, while those with high levels of CD44s gain CSC stemness [44] (Fig. 1A). This evidence concerns the gene CD44 and breast carcinoma.